Industry reports
Editor highlights

Generic Drug Industry in South Korea: Market Research Reports, Statistics and Analysis

» View Public Reports

27 reports

The South Korean Generic Drug Industry : Innovation and Technology Trends

  • Industry report
  • September 2012
  • 53 pages

... Costs ega improving competitiveness increasing market share promoting sustainable pricing quicker access to the market (stm) challenges for the european generic medicines market inquiry identifies ...

Generic Drug in The United States and South Korea : Innovation and Technology Trends

  • Industry report
  • March 2010
  • 2 pages

... New drug. Since they are expected to cost less than an inno- vative drug, they bring new treat- ments to patients who previously could not afford them. They are not generic drugs, which are shown ...

Company Report: Generic Drug in South Korea for Year 2013

  • Company report
  • January 2013
  • 16 pages

... Accounted for 15.1% Of the generic drug market (as of 4q12), followed by cj (13.5%), Hanmi (4.7%), Shinpoong (4.0%), And ilong (3.2%). Recommend yuhan as top pick; ckd maintained as second-preferred stock ...

Company Report: Generic Drug in India, The United States and South Korea for Year 2012

  • Company report
  • November 2012
  • 4 pages

... For any newly innovated medicine. While the move is expected to have a financial impact on generic drug makers in a positive way as it will improves the speed of approval. The proposed generic user fee ...

Company Report: Generic Drug in Japan, South Korea and Switzerland for Year 2012

  • Company report
  • June 2012
  • 2 pages

... To contend with a signifi- cant increase in expenditure on healthcare. Compared with other developed countries there is only a very low generic drug penetra- tion in japan. In 2004, the generics share ...

Company Report: Generic Drug in Japan, South Korea and Switzerland for Year 2012

  • Company report
  • May 2012
  • 2 pages

... Older, japan has to contend with a significant increase in expenditure on healthcare. Compared with other developed countries there is only a very low generic drug penetration in japan. In 2004 ...

Search in Generic Drug Industry

» Purchase Premium Reports (From $ 305 - $ 6 000)

6 reports
Global Biosimilars Market - Products, Applications and Regulations

Global Biosimilars Market - Products, Applications and Regulations

  • $ 4 320
  • Industry report
  • November 2012
  • by Industry Experts

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position ...

Lg Life Sciences: Biosimilars Company Analysis

June 2012 $ 3 800

Asia Pacific Pharma Sector Analysis

June 2012 $ 1 300

Biopharmaceutical In South Korea: South Korea: Generics ...

August 2011 $ 395

South Korea Generics Market

March 2011 $ 6 000

Egis Generics Company Intelligence Report

January 2011 $ 341

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.